Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors

Overview of attention for article published in BMC Cancer, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 948 followers.

Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors https://t.co/af9opH2amu https://t.co/QzvirIMvvx

01 Aug 2022

Reply Repost Favourite

New article: Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors https://t.co/tsAhxEDukJ #lungcancer #oncology https://t.co/kXfw3L0pv5

29 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.